Works matching AU Österborg, Anders

Results: 94
    1
    2
    3

    MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine.

    Published in:
    Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00484-7
    By:
    • Boulouis, Caroline;
    • Kammann, Tobias;
    • Cuapio, Angelica;
    • Parrot, Tiphaine;
    • Gao, Yu;
    • Mouchtaridi, Elli;
    • Wullimann, David;
    • Lange, Joshua;
    • Chen, Puran;
    • Akber, Mira;
    • Rivera Ballesteros, Olga;
    • Muvva, Jagadeeswara Rao;
    • COVAXID study group;
    • Sällberg Chen, Margaret;
    • Healy, Katie;
    • Sobkowiak, Michal;
    • Söderdahl, Gunnar;
    • Blennow, Ola;
    • Österborg, Anders;
    • Mielke, Stephan
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11

    ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells.

    Published in:
    Biomedicines, 2020, v. 8, n. 6, p. 170, doi. 10.3390/biomedicines8060170
    By:
    • Ghaderi, Amineh;
    • Daneshmanesh, Amir Hossein;
    • Moshfegh, Ali;
    • Kokhaei, Parviz;
    • Vågberg, Jan;
    • Schultz, Johan;
    • Olin, Thomas;
    • Harrysson, Sara;
    • Smedby, Karin E;
    • Drakos, Elias;
    • Rassidakis, Georgios Z.;
    • Österborg, Anders;
    • Mellstedt, Håkan;
    • Hojjat-Farsangi, Mohammad
    Publication type:
    Article
    12
    13
    14
    15
    16

    Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: A randomized phase II study from the Nordic Lymphoma Group.

    Published in:
    Leukemia & Lymphoma, 2008, v. 49, n. 1, p. 102, doi. 10.1080/10428190701704647
    By:
    • Kimby, Eva;
    • Jurlander, Jesper;
    • Geisler, Christian;
    • Hagberg, Hans;
    • Holte, Harald;
    • Lehtinen, Tuula;
    • Östenstad, Björn;
    • Hansen, Mads;
    • Österborg, Anders;
    • Lindén, Ola;
    • Sundström, Christer;
    • On Behalf Of The Nordic Lymphoma Group
    Publication type:
    Article
    17
    18

    A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells.

    Published in:
    Pharmaceutics, 2023, v. 15, n. 4, p. 1148, doi. 10.3390/pharmaceutics15041148
    By:
    • Ghaderi, Amineh;
    • Okhovat, Mohammad-Ali;
    • Lehto, Jemina;
    • De Petris, Luigi;
    • Manouchehri Doulabi, Ehsan;
    • Kokhaei, Parviz;
    • Zhong, Wen;
    • Rassidakis, Georgios Z.;
    • Drakos, Elias;
    • Moshfegh, Ali;
    • Schultz, Johan;
    • Olin, Thomas;
    • Österborg, Anders;
    • Mellstedt, Håkan;
    • Hojjat-Farsangi, Mohammad
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Phase III, randomized study of ofatumumab versus physicians’ choice of therapy and standard versus extended-length ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukemia.

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 9, p. 2037, doi. 10.3109/10428194.2015.1122783
    By:
    • Österborg, Anders;
    • Udvardy, Miklós;
    • Zaritskey, Andrey;
    • Andersson, Per-Ola;
    • Grosicki, Sebastian;
    • Mazur, Grzegorz;
    • Kaplan, Polina;
    • Steurer, Michael;
    • Schuh, Anna;
    • Montillo, Marco;
    • Kryachok, Iryna;
    • Middeke, Jan Moritz;
    • Kulyaba, Yaroslav;
    • Rekhtman, Grygoriy;
    • Gorczyca, Michele;
    • Daly, Siobhan;
    • Chang, Chai-Ni;
    • Lisby, Steen;
    • Gupta, Ira
    Publication type:
    Article
    28
    29

    Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas.

    Published in:
    Leukemia & Lymphoma, 2014, v. 55, n. 5, p. 1158, doi. 10.3109/10428194.2013.824077
    By:
    • Högfeldt, Therese;
    • Johnsson, Per;
    • Grandér, Dan;
    • Bahnassy, Abeer A.;
    • Porwit, Anna;
    • Eid, Salem;
    • Österborg, Anders;
    • Zekri, Abdel-Rahman N.;
    • Lundahl, Joachim;
    • Khaled, Mustafa Hussein;
    • Mellstedt, Håkan;
    • Moshfegh, Ali
    Publication type:
    Article
    30
    31

    Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 4, p. 843, doi. 10.3109/10428194.2012.731599
    By:
    • Daneshmanesh, Amir Hossein;
    • Porwit, Anna;
    • Hojjat-Farsangi, Mohammad;
    • Jeddi-Tehrani, Mahmood;
    • Tamm, Katja Pokrovskaja;
    • Grandér, Dan;
    • Lehmann, Sören;
    • Norin, Stefan;
    • Shokri, Fazel;
    • Rabbani, Hodjattallah;
    • Mellstedt, Håkan;
    • Österborg, Anders
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    CYTOKINE THERAPY IN MULTIPLE MYELOMA*.

    Published in:
    British Journal of Haematology, 1996, v. 94, n. 3, p. 425, doi. 10.1046/j.1365-2141.1996.02298.x
    By:
    • PEEST, DIETRICH;
    • BLADÉ, JOAN;
    • HAROUSSEAU, JEAN-LUC;
    • KLEIN, BERNHARD;
    • ÖSTERBORG, ANDERS;
    • SAN MIGUEL, JESUS F.
    Publication type:
    Article
    49
    50